If you liked this article you might like

Experimental Tau Protein Drug Tangled Up in Late-Stage Alzheimer's Study Failure
Biogen (BIIB) Stock Up on CEO Transition, Fueling Sale Speculation
Biogen Should Either a Buyer or a Seller Be
Roger Ailes, Biogen Shake-Up and Other Notable CEO Departures of 2016